FDA Inspection
Douglas Glenn Young, M.D.Douglas Glenn Young, M.D. – FDA Inspection, Jul 7, 2010
Record Details
This FDA Inspection record concerns Douglas Glenn Young, M.D., with an inspection on July 7, 2010, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Douglas Glenn Young, M.D.
- Inspection Date
- July 7, 2010
- Product Type
- Drugs
View Company Profile
ID · 12a8cc78-dcb7-4a16-942e-7a77684698b0
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 673350
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
3- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.60Informed consent
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Douglas Glenn Young, M.D.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| November 20, 2023 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| May 13, 2016 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| February 3, 2011 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| September 24, 2009 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Douglas Glenn Young, M.D.
- FDA Inspection 1223258 - 2023-11-20
- FDA Inspection 971707 - 2016-05-13
- FDA Inspection 708204 - 2011-02-03
- FDA Inspection 614235 - 2009-09-24
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.